Inactive Instrument

News Easton Pharmaceuticals Inc. Other OTC

Equities

EAPH

US2777741057

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)	21-12-29	AQ
EASTON PHARMACEUTICALS INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.	21-12-29	AQ
EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21-12-22	AQ
Parallel Industries Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2021	21-12-22	CI
EASTON PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21-12-22	AQ
EASTON PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	21-12-22	AQ
Easton Pharmaceuticals Inc. cancelled the acquisition of Boutique Hotel and Real Estate Asset in the Heart of Toronto, Ontario, Canada.	19-09-26	CI
Easton Pharmaceuticals Turns to Profit in Q1, Provides Business Update	19-06-13	GL
Easton Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-06-13	CI
Easton Pharmaceuticals Inc. Moves its Corporate Head Office	19-04-30	CI
Easton Pharmaceuticals Inc. acquired Supreme Sweets Inc. from Barbara and Mario Parravano.	19-04-25	CI
Easton Pharmaceuticals Inc. Signs LOI with Licensed Producer of Cannabis to Expand its Operations and Participate in its Cannabis Edibles Division	19-03-27	CI
Easton Pharmaceuticals Inc. Commences Cannabis Edibles Division	19-03-10	CI
Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market	19-03-05	GL
Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives	19-02-05	GL
Easton Pharmaceuticals Inc. Announces Updates on its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives	19-02-05	CI
Easton Announces Completion of Financial Statements With $200,000 in Sales in Quarter Ending Sept. 30th, 2018 and Revenue for Quarter Ending December 31, 2018	19-01-23	GL
Easton Pharmaceuticals Inc. Announces Sales Results for the Quarter Ended September 30, 2018 and December 31, 2018	19-01-23	CI
Easton Pharmaceuticals Inc. Provides Operational Update on CAD 2,600,000 Framing Contract	19-01-11	CI
Easton Announces Status Updates on its $2,600,000 Framing Contract to Construct 150 Homes, Including New Additional Project	19-01-11	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Easton Pharmaceuticals Inc. Other OTC

Equities

EAPH

US2777741057

Summary

Filters